If hepatitis C therapy is so great, why isn't everyone doing it?
- PMID: 29862650
- DOI: 10.1111/ajt.14960
If hepatitis C therapy is so great, why isn't everyone doing it?
Keywords: complication: infectious; economics; editorial/personal viewpoint; health services and outcomes research; infection and infectious agents - viral: hepatitis C; insurance; kidney transplantation/nephrology; liver transplantation/hepatology; organ transplantation in general; quality of care/care delivery.
Comment on
-
The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes.Am J Transplant. 2018 Oct;18(10):2473-2482. doi: 10.1111/ajt.14895. Epub 2018 May 29. Am J Transplant. 2018. PMID: 29701909 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
